156 related articles for article (PubMed ID: 27345334)
1. Mutations in the drug resistance-determining region of Mycobacterium lepromatosis isolated from leprosy patients in Mexico.
Kai M; Fafutis-Morris M; Miyamoto Y; Mukai T; Mayorga-Rodriguez J; Rodriguez-Castellanos MA; Martínez-Guzman MA; Matsuoka M
J Dermatol; 2016 Nov; 43(11):1345-1349. PubMed ID: 27345334
[TBL] [Abstract][Full Text] [Related]
2. The leprosy agents Mycobacterium lepromatosis and Mycobacterium leprae in Mexico.
Han XY; Sizer KC; Velarde-Félix JS; Frias-Castro LO; Vargas-Ocampo F
Int J Dermatol; 2012 Aug; 51(8):952-9. PubMed ID: 22788812
[TBL] [Abstract][Full Text] [Related]
3. Leprosy Drug Resistance Surveillance in Colombia: The Experience of a Sentinel Country.
Beltrán-Alzate C; López Díaz F; Romero-Montoya M; Sakamuri R; Li W; Kimura M; Brennan P; Cardona-Castro N
PLoS Negl Trop Dis; 2016 Oct; 10(10):e0005041. PubMed ID: 27706165
[TBL] [Abstract][Full Text] [Related]
4. Diffuse Lepromatous Leprosy Due to Mycobacterium lepromatosis in Quintana Roo, Mexico.
Han XY; Quintanilla M
J Clin Microbiol; 2015 Nov; 53(11):3695-8. PubMed ID: 26311856
[TBL] [Abstract][Full Text] [Related]
5. qPCR-High resolution melt analysis for drug susceptibility testing of Mycobacterium leprae directly from clinical specimens of leprosy patients.
Araujo S; Goulart LR; Truman RW; Goulart IMB; Vissa V; Li W; Matsuoka M; Suffys P; Fontes AB; Rosa PS; Scollard DM; Williams DL
PLoS Negl Trop Dis; 2017 Jun; 11(6):e0005506. PubMed ID: 28570560
[TBL] [Abstract][Full Text] [Related]
6. Drug resistance in Mycobacterium leprae from patients with leprosy in China.
Liu D; Zhang Q; Sun Y; Wang C; Zhang Y; Fu X; Chen M; Zhou G; Yu X; Wang J; Liu H; Zhang F
Clin Exp Dermatol; 2015 Dec; 40(8):908-11. PubMed ID: 25991507
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the leprosy agents Mycobacterium leprae and Mycobacterium lepromatosis in four countries.
Han XY; Aung FM; Choon SE; Werner B
Am J Clin Pathol; 2014 Oct; 142(4):524-32. PubMed ID: 25239420
[TBL] [Abstract][Full Text] [Related]
8. Case of diffuse lepromatous leprosy associated with "Mycobacterium lepromatosis".
Vera-Cabrera L; Escalante-Fuentes WG; Gomez-Flores M; Ocampo-Candiani J; Busso P; Singh P; Cole ST
J Clin Microbiol; 2011 Dec; 49(12):4366-8. PubMed ID: 22012006
[TBL] [Abstract][Full Text] [Related]
9. Leprosy Caused by Mycobacterium lepromatosis.
Romero-Navarrete M; Arenas R; Han XY; Vega-Memije ME; Castillo-Solana AD
Am J Clin Pathol; 2022 Dec; 158(6):678-686. PubMed ID: 36200553
[TBL] [Abstract][Full Text] [Related]
10. Insight into the evolution and origin of leprosy bacilli from the genome sequence of Mycobacterium lepromatosis.
Singh P; Benjak A; Schuenemann VJ; Herbig A; Avanzi C; Busso P; Nieselt K; Krause J; Vera-Cabrera L; Cole ST
Proc Natl Acad Sci U S A; 2015 Apr; 112(14):4459-64. PubMed ID: 25831531
[TBL] [Abstract][Full Text] [Related]
11. Construction and Analysis of the Complete Genome Sequence of Leprosy Agent Mycobacterium lepromatosis.
Silva FJ; Santos-Garcia D; Zheng X; Zhang L; Han XY
Microbiol Spectr; 2022 Jun; 10(3):e0169221. PubMed ID: 35467405
[TBL] [Abstract][Full Text] [Related]
12. Mycobacterium leprae: pathogenic agent in leprosy. Discovery of new species Mycobacterium lepromatosis. Perspectives in research and diagnosis of leprosy.
Kowalska M; Kowalik A
Int Marit Health; 2012; 63(4):213-8. PubMed ID: 24595978
[TBL] [Abstract][Full Text] [Related]
13. Identification of
Torres-Guerrero E; Sánchez-Moreno EC; Atoche-Diéguez CE; Carrillo-Casas EM; Arenas R; Xicohtencatl-Cortes J; Hernández-Castro R
Ann Dermatol; 2018 Oct; 30(5):562-565. PubMed ID: 33911479
[TBL] [Abstract][Full Text] [Related]
14. The frequency of drug resistance mutations in Mycobacterium leprae isolates in untreated and relapsed leprosy patients from Myanmar, Indonesia and the Philippines.
Matsuoka M; Budiawan T; Aye KS; Kyaw K; Tan EV; Cruz ED; Gelber R; Saunderson P; Balagon V; Pannikar V
Lepr Rev; 2007 Dec; 78(4):343-52. PubMed ID: 18309708
[TBL] [Abstract][Full Text] [Related]
15. Mycobacterium leprae and Mycobacterium lepromatosis Infection: a Report of Six Multibacillary Cases of Leprosy in the Dominican Republic.
Fernández JDP; Pou-Soarez VE; Arenas R; Juárez-Duran ER; Luna-Rojas SL; Xicohtencatl-Cortes J; Martínez-Chavarría LC; Martínez-Hernández F; Hernández-Castro R
Jpn J Infect Dis; 2022 Jul; 75(4):427-430. PubMed ID: 35354704
[TBL] [Abstract][Full Text] [Related]
16. Identification of the leprosy agent Mycobacterium lepromatosis in Singapore.
Han XY; Sizer KC; Tan HH
J Drugs Dermatol; 2012 Feb; 11(2):168-72. PubMed ID: 22270197
[TBL] [Abstract][Full Text] [Related]
17. A drug-resistant leprosy case detected by DNA sequence analysis from a relapsed Mexican leprosy patient.
Lopez-Roa RI; Fafutis-Morris M; Masanori M
Rev Latinoam Microbiol; 2006; 48(3-4):256-9. PubMed ID: 18293659
[TBL] [Abstract][Full Text] [Related]
18. Possible mode of emergence for drug-resistant leprosy is revealed by an analysis of samples from Mexico.
Matsuoka M; Suzuki Y; Garcia IE; Fafutis-Morris M; Vargas-González A; Carreño-Martinez C; Fukushima Y; Nakajima C
Jpn J Infect Dis; 2010 Nov; 63(6):412-6. PubMed ID: 21099091
[TBL] [Abstract][Full Text] [Related]
19. Isolation of Mycobacterium lepromatosis and Development of Molecular Diagnostic Assays to Distinguish Mycobacterium leprae and M. lepromatosis.
Sharma R; Singh P; McCoy RC; Lenz SM; Donovan K; Ochoa MT; Estrada-Garcia I; Silva-Miranda M; Jurado-Santa Cruz F; Balagon MF; Stryjewska B; Scollard DM; Pena MT; Lahiri R; Williams DL; Truman RW; Adams LB
Clin Infect Dis; 2020 Nov; 71(8):e262-e269. PubMed ID: 31732729
[TBL] [Abstract][Full Text] [Related]
20. Nested PCR and the TaqMan SNP Genotyping Assay enhanced the sensitivity of drug resistance testing of Mycobacterium leprae using clinical specimens of leprosy patients.
Chen X; He J; Liu J; You Y; Yuan L; Wen Y
PLoS Negl Trop Dis; 2019 Dec; 13(12):e0007946. PubMed ID: 31881061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
